Tue 17 Nov 2026 08:28:38 BST
Search Company
*

Active Substance
New Active Substance
Search Site
--
*

Create Site
--
*
*
*
*
*
*
Update Site
Current data stored in EudraGMDP databaseCurrent data stored in OMS
--
Characters remaining:4000/4000
New Active Substance Importation
Active Substance*
Active Substance (English):
Active Substance (NL):
NCA Reference Key:
3rd Country Manufacturer
3rd Country ManufacturerOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

3rd Country Distributor
3rd Country DistributorOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

Information Messages
  • The WDA has been withdrawn, withdrawn date is: 2025-12-12
  • RTF Template


    Norwegian Medical Products Agency

    UNION FORMAT FOR A WHOLESALE DISTRIBUTION AUTHORISATION

    Veterinary medicinal products


    1. Authorisation Number

    :

    25/13068-5

    2. Name of Authorisation Holder

    :

    Salfarm Scandinavia AS

    (ORG-100018900 / LOC-100052110)

    3. Address(es) of Site(s)

    :

    Fridtjof Nansens Plass 4, Oslo, 0160, Norway 




    4. Legally registered address of Authorisation Holder

    :

    Fridtjof Nansens Plass 4, Oslo, 0160

    5. Scope of authorisation

    :

    ANNEX 1

    6. Legal basis of authorisation

    :

    Art. 99 of Regulation (EU) 2019/6

    7. Name of responsible officer of the competent authority of the member state granting the wholesale distribution authorisation

    :

    Confidential, Confidential

    8. Signature

    :


    9. Date

    :

    2025-07-01

    10. Annexes attached

    :

    Annex 1 Scope of wholesale distribution authorisation

    Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number

    Annex 3 (Optional) Name(s) of responsible person(s)

    Annex 4 (Optional) Date of Inspection on which authorisation was granted

    Annex 5 (Optional) Additional provisions based on national requirements


    ANNEX 1

    SCOPE OF WHOLESALE DISTRIBUTION AUTHORISATION



    Name and address of the site: Salfarm Scandinavia AS

    (ORG-100018900 / LOC-100052110)

    , Fridtjof Nansens Plass 4, Oslo, 0160, Norway   



    Veterinary medicinal products


    1. MEDICINAL PRODUCTS

       1.1. with a Marketing Authorisation or registration in EEA country(s)

       1.2. without a Marketing Authorisation or registration in the EEA and intended for EEA market*


    2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

       2.1. Procurement 

       2.3. Supply 


    3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

       3.1. Narcotic or psychotropic products** 

       3.2. Products requiring low temperature handling 

         3.2.1. Temperatures between 2 to 8 °C 

       3.3. Other products: (please specify here or make a reference to Annex 5) Free samples | Immunological medicinal products




    Any restrictions or clarifying remarks (for all users):  Section 1.2 applies to the medicinal product BotVax B vet, having been granted exemption from Marketing Authorisation, cf. Regulation relating to Veterinary Medicinal Products chapter 4 and section 11-2, the Act relating to Medicinal Products section 2d last paragraph, and Regulation 2019//6/EU articles 112-114. This medicinal product is restricted for use on animals in Norway which have been granted such exemption.
    BotVax B vet is manufactured in the USA, and NoMA hereby confirms that the product may be imported via Sweden.



    *Art. 5 of Directive 2001/83/EC, Art. 83 of Regulation (EC) 726/2004 and Art. 110 of Regulation 2019/6.

    **Without prejudice to further authorisations as may be required according to national legislation.






    Reason for Withdrawing:

    A new version has been submitted.








    Union Format for a Wholesale Distribution Authorisation

    25/13068-5


    Page 1





    Loading, please wait